<DOC>
	<DOCNO>NCT01914887</DOCNO>
	<brief_summary>The aim study evaluate feasibility safety endoscopic injection adipose tissue-derived mesenchymal stem cell human subject moderate active ulcerative colitis , assess absence adverse event associate investigational drug , evaluate efficacy treatment induce remission moderate active ulcerative colitis , improvement disease activity index , quality life index , endoscopic index .</brief_summary>
	<brief_title>Allogeneic Adipose Tissue-derived Mesenchymal Stem Cells Induction Remission Ulcerative Colitis</brief_title>
	<detailed_description>Mesenchymal stem cell ( MSC ) may therapeutic option disease associate severe inflammation auto-immune disease , due immunomodulatory anti-inflammatory property . A number clinical trial conduct worldwide test th efficacy MSC , mainly isolate bone marrow , different condition , Graft Versus host Disease , refractory Crohn 's Disease , ischemic stroke , acute myocardial infarction , type I Diabetes Mellitus , Chronic Obstructive Pulmonary Disease . Usually , route administration cell study intravenous . Local injection MSC fistulizing Crohn 's Disease proven efficacious . Endoscopy routinary technique evaluation gastrointestinal colonic condition . The purpose study evaluate safety efficacy intracolonic injection use colonoscope allogeneic adipose tissue-derived MSC patient moderate active ulcerative colitis .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<criteria>Patients either sex age 18 year old Signed informed consent Patients ulcerative colitis diagnose least 6 month early accordance usual criterion Leftsided colitis moderate activity define modify TrueloveWitts score 11 21 , response 4 week treatment oral and/or topical 5aminosalicylates Negative pregnancy test woman childbearing potential ( menarche menopause ) use consistently correctly highly effective ( i.e . le 1 % failure rate per year ) method birth control Mental disability impedes adequate understand study associate procedure Extensive colitis Patients impaired general state require , accord investigator judgment , immediate treatment corticosteroid and/or antiTumor Necrosis Factor ( TNF ) and/or surgery Patients fulfill criterion corticodependency ongoing treatment corticosteroid Patients previous colectomies Known history alcohol addictive substance abuse History malignant disease Patients participate clinical trial investigational drug within 6 month prior enrolment study Patients know allergy penicillin , gentamicin , aminoglycosides , human serum albumin ( HSA ) , Dulbecco 's modify Eagle medium ( DMEM ) , material bovine origin Pregnant breastfeed woman Presence severe concomitant diseases Patients suspicion Crohn ? enterocolitis , indeterminate colitis , ischaemic colitis , radiation colitis , diverticular disease associate colitis , microscopic colitis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Ulcerative Colitis</keyword>
	<keyword>Inflammatory Bowel Disease</keyword>
	<keyword>Mesenchymal stem cell</keyword>
</DOC>